Dr. Zheng has served as CEO and a member of our board of directors since he co-founded the company in 2012. He has over 25 years of biopharmaceutical industry experience in the autoimmune disease and inflammation therapeutic areas. Prior to co-founding Connect, Dr. Zheng was Director of Immunology at Arena Pharmaceuticals where he oversaw its … Read more
Dr. Pan is a co-founder of Connect and has served as President and Chairman of the Board of Directors since May 2012. He has over 25 years of experience in biopharmaceutical R&D, including 10 years in Europe and North America. Prior to co-founding Connect, Dr. Pan co-founded and led Crown Bioscience Inc., a U.S. venture-backed company … Read more
Dr. Chin Lee joined Connect as Chief Medical Officer in March 2022 and brings more than 15 years of clinical research and development experience in the biopharmaceutical industry across multiple therapeutic areas. Prior to Connect, Dr. Lee served as Vice President, Head of Clinical Science, and Chief Medical Officer at Theravance Biopharma, Inc. Previously, Dr. … Read more
Mr. Bian has served as General Counsel and Chief Compliance Officer since August 2021. He joined Connect Biopharma from Guardant Health, Inc., a publicly traded precision oncology diagnostics company, based in Redwood City, California, where he served as Senior Counsel.
Steven Chan joined Connect as CFO in November 2021. He brings 25+ years of financial experience leading life science, technology, financial services, and manufacturing companies. Most recently, he was CFO at Delphon Industries, an advanced materials manufacturer based in the Bay Area. Prior to that, he built out the finance teams at Arcus Biosciences and … Read more
Dr. Sun has over 20 years of experience in pharmaceutical development of biologics focused on process development, CMC, and manufacturing operations. Prior to joining Connect, Dr. Sun served as Chief Technology Officer and Vice President of Manufacturing at Autekbio Diagnostics. Prior to serving at Autekbio Diagnostics, Dr. Sun supported drug development at PERCIVIA, UCB Pharma, Shire Pharmaceuticals … Read more
Dr. Raúl Collazo joined the Company in November 2021 to lead the Medical Affairs function. He has over 20 years of Medical Affairs experience in small biotech and large pharmaceutical environments. Additionally, he brings extensive expertise advising pre-commercial life science companies on medical/scientific affairs, compliance, operations, and corporate strategy through his own consulting firm. Prior … Read more
Dr. Longphre has more than 20 years of biopharmaceutical industry experience in immunology, inflammation and respiratory therapeutic areas. Prior to joining Connect, Dr. Longphre was Director of Clinical Research at Novartis where she oversaw development of inhaled anti-inflammatory combination products to treat lung disease. Prior to that role, Dr. Longphre was a founding scientist at Aerovance, … Read more
Dr. QJ Wang joined Connect in July 2021 to lead the nonclinical programs. He is an experienced pharmacology and toxicology professional with about 30 years of experience working in various capacities in pre/nonclinical drug R&D. Prior to joining the company, he was a Senior Director of R&D at FibroGen, San Francisco. QJ is a key … Read more
Mr. McDade is Co-founder and Managing Partner of the Qiming US Healthcare Fund, a venture capital firm based in Seattle and formed in January 2017. Prior to Qiming, from April 2008 until his retirement in October 2016, Mr. McDade was EVP and Chief Operating Officer at UCB S.A., a Belgian biopharmaceutical company. From 2002 to … Read more